ADMA - ADMA Biologics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.455B

Cash

51.35M

Avg Qtr Burn

N/A

Short % of Float

3.26%

Insider Ownership

2.63%

Institutional Own.

77.45%

Qtr Updated

12/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Nabi-HB® Details Hepatitis B	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ASCENIV™ Details Immunodeficiency, Autoimmune disease, Primary humoral immunodeficiency	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BIVIGAM® Details Autoimmune disease, Immunodeficiency, Primary humoral immunodeficiency	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.